RY

Rajani Yadav

Director Director DIN 02779527
DIN 02779527 First appointment Oct 2009 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Oct 2009
Shareholding value β€’β€’β€’β€’ Premium profile

About Rajani Yadav

Data last updated:

Rajani Yadav was a Director at Aprikos Pharma Private Limited (2009–2011) and Director at Arikos Pharmaceuticals Private Limited (from 2011). The companies operate in Pharma.

DIN 02779527
Primary Designation Director
Industry Pharma
First Appointment 27 Oct 2009
Oldest Company Age 15 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Aprikos Pharma Private Limited U74900DL2009PTC195529
Director27 Oct 20092009₹22.8 Lakh (FY 2015)Converted To Llp
Director05 Jan 20112011Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Arikos Pharmaceuticals Private Limited
Aprikos Pharma Private Limited
Premium access

Shareholding and investment profile for Rajani Yadav

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rajani Yadav

Rajani Yadav was first appointed on 27 Oct 2009 as Director at Aprikos Pharma Private Limited. The most recent appointment on record is 05 Jan 2011 at Arikos Pharmaceuticals Private Limited.

Rajani Yadav held 2 earlier board appointments: Aprikos Pharma Private Limited (Director, 27 Oct 2009 to 27 Apr 2011); Arikos Pharmaceuticals Private Limited (Director, from 05 Jan 2011).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available